Perrigo is facing a High Court row over its insurance coverage for a US securities class action brought by investors against the global healthcare giant. Ten insurance companies, including AIG, Allianz, Chubb, and Lloyds have recently lodged proceedings against the Irish-registered pharmaceutical business which is embroiled in a hefty damages lawsuit in the District of New Jersey. The publicly traded company, along with former executives, are fighting shareholder claims that date back to Mylan’s failed $26 billion hostile takeover bid in November 2015. At the time of Mylan’s unsolicited offer, Perrigo was telling investors that its competitor had substantially underestimated…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .